[Federal Register Volume 61, Number 223 (Monday, November 18, 1996)]
[Rules and Regulations]
[Pages 58630-58631]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-29388]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
21 CFR Part 510
New Animal Drugs; Change of Sponsor Address
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect a change of sponsor address for Alstoe,
Ltd., Animal Health.
EFFECTIVE DATE: November 18, 1996.
FOR FURTHER INFORMATION CONTACT: Thomas J. McKay, Center for Veterinary
Medicine (HFV-102), Food and Drug Administration, 7500 Standish Pl.,
Rockville, MD 20855, 301-827-0213.
SUPPLEMENTARY INFORMATION: Alstoe, Ltd., Animal Health, 19 Foxhill,
Whissendine, Oakham, Rutland, U.K. has informed FDA that it has changed
its address to Granary Chambers, 37-39 Burton St., Melton Mowbray,
Leicestershire LE13 1AF, England. Accordingly, the agency is amending
the regulations in 21 CFR 510.600(c)(1) and (c)(2) to reflect the new
address.
List of Subjects in 21 CFR Part 510
Administrative practice and procedure, Animal drugs, Labeling,
Reporting and recordkeeping requirements.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is
amended as follows:
PART 510--NEW ANIMAL DRUGS
1. The authority citation for 21 CFR part 510 continues to read as
follows:
Authority: Secs. 201, 301, 501, 502, 503, 512, 701, 721 of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 331, 351, 352,
353, 360b, 371, 379e).
Sec. 510.600 [Amended]
2. Section 510.600 Names, addresses, and drug labeler codes of
sponsors of approved applications is amended in the table in paragraph
(c)(1) in the entry for ``Alstoe, Ltd., Animal Health'' and in the
table in paragraph (c)(2) in the entry for ``062408'' by removing ``19
Foxhill, Whissendine, Oakham, Rutland, U.K.''
[[Page 58631]]
and by adding in its place ``Granary Chambers, 37-39 Burton St., Melton
Mowbray, Leicestershire LE13 1AF, England''.
Dated: October 29, 1996.
Andrew J. Beaulieau,
Deputy Director, Office of New Animal Drug Evaluation, Center for
Veterinary Medicine.
[FR Doc. 96-29388 Filed 11-15-96; 8:45 am]
BILLING CODE 4160-01-F
